Table 2.
Plasma MDA concentration and new-onset diabetes after transplantation (NODAT) in renal transplant recipients (RTR, n = 516).
| NODAT | HR (95% CI) Per 1-SD | p |
|---|---|---|
| Crude model | 0.61 (0.41–0.92) | 0.02 |
| Model 1 | 0.63 (0.42–0.94) | 0.02 |
| Model 2 | 0.54 (0.36–0.83) | <0.01 |
| Model 3 | 0.54 (0.35–0.82) | <0.01 |
| Model 4 | 0.56 (0.37–0.85) | <0.01 |
| Model 5 | 0.55 (0.36–0.83) | <0.01 |
| Model 6 | 0.55 (0.36–0.83) | <0.01 |
In total, 56 (11%) RTR developed NODAT. Model 1: crude model plus adjustment for demographic and anthropometric characteristics. Model 2: model 1 plus adjustment for metabolism-related variables. Model 3: model 2 plus adjustment for lifestyle characteristics. Model 4: model 3 plus adjustment for transplantation-related data. Model 5: model 4 plus adjustment for immunosuppressive therapy. Model 6: model 5 plus adjustment for inflammation.